A former Sanofi-Genzyme employee is accusing the company of inappropriately seeking confidential patient information, as part of a lawsuit alleging her wrongful termination.

The lawsuit, filed in late December in Massachusetts federal court, says the former Sanofi-Genzyme employee made a formal, internal complaint about the inappropriate request for confidential information, after which she experienced “harassment” and “discrimination … in retaliation for the reports she made about [her manager’s] efforts to obtain confidential patient data.”

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • This is the tip of the iceberg people. That confidential data is very valuable, and it has already been collected adncollated form millions of Americans. All of this data is sold to the highest bidder, and has had no positive benefit for anyone. People should be asking, Who is buying this data. The big Elephant in the room……

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy